Prescribing for Dry Eye Disease - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Prescribing for Dry Eye Disease

The Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) III report, which was recently released, includes an updated prescribing algorithm based on DED etiology or pathogenic drivers.

  • By

  • LISA HORNICK, OD, MBA, FAAO

  • July 1, 2025

  • 7 min

Share

Objective:

Emphasize the significance of the TFOS DEWS III report in shaping treatment options.

Approach:
    Key Findings:
    • Include specific examples of therapies for each driver.
    Interpretation:

    Mention implications for clinical practice.

    Limitations:
    • Specify how the lack of clinical trial data affects treatment decisions.
    Conclusion:

    Reiterate the importance of individualized treatment plans.

    Sources:

Original Source(s)

Prescribing for Dry Eye Disease

  • by LISA HORNICK, OD, MBA, FAAO

  • July 1, 2025

Related Content

Managing Persistent Scleral Lens Intolerance in Post-LASIK Ectasia

Insights into the quality and guideline consistency of dry eye disease treatment videos on Chinese short-video platforms

Standardizing AI for Dry Eye

Expert consensus aims to set professional standards for the use of AI in dry eye diagnosis, monitoring, and personalized treatment

  • June 29, 2026

  • 3 min